Results 91 to 100 of about 45,547 (280)

Recurrent Orbital Myositis: A Case Report

, 2007
Nonspesific orbital inflammatory syndromes (orbital pseudotumor) are a heterogeneous group of conditions. Orbital myositis is a subtype of this group involving one or more orbital muscles. It is quite rare in children. Corticosteroids are the mainstay of
Eda Ayberkin, Emine Suskan, Deniz Tekin, Suat Fitöz, Erdal İnce   +4 more
core  

In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype.

, 2005
The aim of this study was to investigate HLA class II associations in polymyositis (PM) and dermatomyositis (DM), and to determine how these associations influence clinical and serological differences.
Hector Chinoy, Salway, F, Ollier, WE, Oddis, C. V., Noreen Fertig, Fertig, N, Salway, F., Fertig, N., Isenberg, DA, Silman, AJ, Cooper, R. G., Isenberg, D. A., Alan J Silman, Chinoy, H., Ollier, W. E., Chinoy, H, Thomson, W, Shephard, N., Brian D Tait, Silman, A. J., William ER Ollier, Neil Shephard, Chester V Oddis, Robert G Cooper, Shephard, N, Tait, BD, Thomson, W., Tait, B. D., UK Adult Onset Myositis Immunogenetic Collaboration, (AOMIC), Cooper, RG, Wendy Thomson, Fiona Salway, David A Isenberg, Oddis, CV   +33 more
core   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 CAR‐T Cell Therapy in Progressive Systemic Sclerosis

Arthritis &Rheumatology, Accepted Article.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T‐cell therapy in patients with progressive systemic sclerosis. Methods Patients with progressive systemic sclerosis received CD19 CAR‐T cell therapy and were followed longitudinally for safety, clinical efficacy, immune ...
Chenhan Jia, Wanyi Lin, Zhangyi Zhao, Fenglin Wu, Chaoyu Gu, Yuankai Sun, Zhe Ding, Chang Wei, Xinyu Li, Cuiwei Xie, Peng Xia, Zhen Xia, Xuesong Liu, Shaoying Yang, Chunyan Zhang, Hanlin Yin, Liangjing Lu   +16 more
wiley   +1 more source

Myositis ossificans in the diabetic foot: a review of the literature with an illustrative case series

JRSM Open, 2019
Objective Myositis ossificans is a rare non-neoplastic form of heterotopic ossification most commonly described after trauma or surgery, in the diabetic foot. Design We provide a review of the literature including three illustrative cases.
Vivek Sharma, Dhiraj Sharma, Heather Dinar, Ketan K Dhatariya   +3 more
doaj   +1 more source

Morphoea with Myositis: A Rare Association [PDF]

, 2011
In this case, we describe an unusual presentation of a young woman with a rash typical of morphoea (confirmed on biopsy), who went on to develop myositis in an atypical distribution.
Claire Gorman, Richard Bull, Mary Sommerlad   +2 more
core   +1 more source

Patients on statins with elevated transaminases: Frequency of follow‐up creatine kinase testing and gastroenterology referral

British Journal of Clinical Pharmacology, EarlyView.
Abstract Purpose To quantify how often creatine kinase (CK) is measured after newly elevated aminotransferases in statin users, and whether absent CK data are associated with gastroenterology (GI) referrals. Methods Retrospective chart review of adult outpatients on statins with a first alanine/aspartate aminotransferase (ALT/AST) elevation during a 5 ...
Faris Shweikeh, Anas Kartoumah, Rajshri Joshi, Anjali Nadihaan, Mohammed Mouchli, Inderprit Singh   +5 more
wiley   +1 more source

Idiopathic Inflammatory Myopathies; Association with Overlap Myositis and Syndromes: Classification, Clinical Characteristics, and Associated Autoantibodies

, 2016
Idiopathic inflammatory myopathies (IIM) are traditionally identified as a group of disorders that target skeletal muscle due to autoimmune dysfunction.
Pari Basharat
core  

High specificity of myositis specific autoantibodies for myositis compared with other neuromuscular disorders.

, 2005
Contains fulltext : 32585.pdf (Publisher’s version ) (Closed access)Myositis specific autoantibodies (MSAs) are proven to be specific for myositis compared with other inflammatory connective tissue diseases.
Brenk, L. van, Engelen, B.G.M. van, Venrooij, W.J.W. van, Hengstman, G.J.D., Padberg, G.W.A.M., Vree Egberts, W.T.M., Borm, G.F., Kooi, E.L. van der, Van Brenk, L.   +8 more
core   +1 more source

Biomaterial design strategies for enhancing mitochondrial transplantation therapy

BMEMat, EarlyView.
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang, Yushan Zhang, Hang Li, Sirui Peng, Donghao Lyu, Chunxiao Zhou, Sheng Ding, Zujian Feng, Pingsheng Huang, Chuangnian Zhang, Hongjun Wang, Deling Kong, Weiwei Wang   +12 more
wiley   +1 more source

Nonbacterial Myositis

Current Infectious Disease Reports, 2010
Infectious myositis is defined as an infection of a skeletal muscle. Infectious myositis is most commonly caused by bacteria; however, a variety of viral, parasitic, and fungal agents may also cause myositis. The pathogenesis of nonbacterial infectious myositis is via direct or hematogenous infection of the musculature or immune mechanisms.
openaire   +3 more sources